resist
respiratori
diseas
cattl
requir
host
defens
mechan
protect
pathogen
evolv
sophist
strategi
evad
includ
alter
function
pulmonari
macrophag
induct
inflammatori
respons
caus
lung
injuri
sepsi
aim
studi
clarifi
mechan
respons
vascular
chang
occur
lung
calv
infect
bovin
viral
diarrhea
viru
bvdv
challeng
later
bovin
herpesviru
type
evalu
role
develop
patholog
lesion
organ
purpos
pulmonari
lesion
compar
coinfect
calv
healthi
anim
inocul
immunohistochem
ino
factorviii
ultrastructur
studi
group
calv
present
import
vascular
alter
produc
fibrin
microthrombi
platelet
aggreg
within
blood
vessel
find
earlier
sever
coinfect
group
indic
concomit
bvdv
lung
disrupt
pulmonari
homeostasi
facilit
establish
inflammatori
procoagul
environ
modul
inflammatori
mediat
releas
pulmonari
regard
coinfect
calv
spite
present
greater
number
singleinfect
group
show
signific
decreas
ino
express
coincid
presenc
coagul
lesion
moreov
anim
preinocul
bvdv
display
alter
respons
proinflammatori
cytokin
play
key
role
activ
immun
respons
well
local
cellmedi
respons
bovin
respiratori
diseas
complex
brdc
import
problem
cattl
industri
often
result
sever
econom
loss
fatal
bovin
respiratori
infect
multifactori
diseas
associ
primari
viral
infect
follow
secondari
bacteri
infect
frequent
character
concurr
infect
sever
pathogen
etiolog
agent
relat
feedlot
pneumonia
includ
bovin
viral
diarrhea
viru
bovin
herpesviru
type
bovin
viru
bovin
respiratori
syncyti
viru
bovin
adenoviru
bovin
coronaviru
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
mycoplasma
spp
resist
respiratori
diseas
cattl
requir
host
defens
mechan
protect
viral
bacteri
pathogen
also
evolv
sophist
strategi
evad
host
immun
respons
includ
among
other
alter
pulmonari
macrophag
function
induct
profound
inflammatori
respons
caus
lung
injuri
sepsi
inflammatori
process
protect
mechan
occur
respons
trauma
infect
tissu
injuri
increas
blood
suppli
enhanc
vascular
permeabl
migrat
immun
cell
occur
damag
site
process
play
central
role
manag
differ
immunopatholog
phenomena
secret
inflammatori
mediat
nitric
oxid
prostaglandin
proinflammatori
cytokin
tumor
necrosi
interleukin
il
potent
vasodil
act
maintain
vascular
tone
function
within
vessel
wall
gener
larginin
nitric
oxid
synthas
no
enzym
three
main
isoform
no
distinct
function
pattern
express
endotheli
no
neuron
no
induc
no
ino
highli
express
prostaglandin
import
inflammatori
mediat
implic
vascular
homeostasi
sinc
low
level
prevent
revers
aggreg
platelet
induc
vasodil
molecul
produc
arachidon
acid
metabolit
catalysi
proinflammatori
cytokin
induc
integrin
express
redistribut
leukocyt
contribut
recruit
activ
site
inflamm
well
increas
vascular
permeabl
tissu
injuri
evid
inflammatori
cytokin
main
orchestr
inflammatori
cascad
brdc
detect
high
level
airway
cattl
infect
respiratori
pathogen
bvdv
pestiviru
although
primari
agent
pathogenesi
brdc
suppress
host
immun
system
increas
risk
secondari
infect
thu
enhanc
pulmonari
colon
pathogen
mechan
immunosuppress
action
bvdv
object
debat
includ
chang
relat
decreas
lymphocyt
prolifer
sever
lymphoid
deplet
lymphoid
tissu
decreas
chemotaxi
phagocyt
activ
increas
product
prostaglandin
increas
synthesi
respons
lipopolysaccharid
impair
product
proinflammatori
cytokin
therefor
aim
studi
clarifi
mechan
respons
ultrastructur
histopatholog
chang
occur
lung
calv
preinfect
bvdv
challeng
later
well
analyz
role
appear
lesion
thu
work
contribut
gain
better
understand
viru
predispos
secondari
airborn
infect
experiment
design
collect
sampl
describ
risald
et
al
briefli
twentyfour
friesian
calv
month
old
bvdv
antigen
antibodi
ab
free
hous
anim
experiment
center
cordoba
univers
spain
anim
adjust
period
one
week
studi
start
separ
three
group
base
inocul
protocol
twelv
calv
inocul
intranas
ml
suspens
noncytopath
strain
titrat
tissu
cultur
infect
dose
tcid
ml
courtesi
institut
virologi
tiho
hannov
germani
twelv
day
later
calv
show
neither
clinic
sign
bvdv
viraemia
challeng
ml
strain
iowa
contain
tcid
ml
courtesi
hipra
laboratori
girona
spain
group
two
calv
group
use
bvdv
infect
control
time
ten
calv
inocul
group
two
uninfect
ui
anim
use
neg
control
receiv
intranas
ml
tissu
cultur
fluid
free
virus
time
point
inocul
defin
day
viru
inocul
clinic
examin
perform
daili
order
determin
number
platelet
edta
blood
obtain
coccyg
vein
nasal
swab
sampl
collect
hour
postinocul
postinocul
dpi
infect
calv
sedat
xylazin
rompun
w
solut
bayer
healthcar
kiel
germani
euthan
overdos
thiopentalsodium
thiovet
w
vet
limit
leyland
lancashir
uk
batch
two
dpi
two
anim
group
kill
dpi
inocul
use
bvdv
infect
control
group
contrari
two
neg
control
anim
euthan
end
studi
use
ui
control
group
experiment
procedur
carri
accord
code
practic
hous
care
anim
use
scientif
procedur
approv
european
econom
commun
amend
direct
euthan
calv
subject
necropsi
examin
sampl
collect
lung
immedi
frozen
virolog
studi
likewis
fix
buffer
formalin
solut
histopatholog
immunohistochem
studi
well
glutaraldehyd
pb
ultrastructur
analysi
lung
tissu
sampl
analyz
discard
infect
secondari
bacteri
pathogen
subject
microbiolog
routin
cultur
xylos
lysin
deoxychol
agar
macconkey
agar
blood
agar
use
standard
procedur
bacteria
isol
sampl
rneasi
lipid
tissu
kit
qiagen
use
extract
bvdv
ribonucl
acid
rna
lung
sampl
accord
manufactur
instruct
rna
subject
one
step
realtim
revers
transcript
plu
polymeras
chain
reaction
rtpcr
use
primer
taqman
probe
concentr
conserv
region
reaction
perform
use
real
time
readi
rna
viru
master
roch
mannheim
germani
lightcycl
accord
manufactur
instruct
sampl
cycl
threshold
valu
less
equal
consid
posit
posit
control
ncp
strain
tcid
ml
realtim
pcr
analysi
deoxyribonucl
acid
dna
extract
lung
sampl
use
genom
dna
tissu
kit
machereynagel
germani
perform
accord
oie
terrestri
manual
analyz
result
appli
detector
appli
biosystem
usa
sampl
cycl
threshold
valu
less
equal
consid
posit
posit
control
strain
iowa
tcid
ml
glutaraldehydefix
sampl
postfix
osmium
tetroxid
dehydr
aceton
embed
epon
w
fluka
chemi
ag
buch
switzerland
section
nm
counterstain
uranyl
acet
lead
citrat
examin
philip
transmiss
electron
microscop
formalinfix
sampl
dehydr
grade
seri
alcohol
xylol
embed
paraffin
wax
routin
techniqu
light
microscopi
sampl
section
stain
differ
method
haematoxylineosin
fraser
lendrum
techniqu
process
immunohistochem
studi
use
avidinbiotinperoxidas
complex
abc
method
abc
method
immunohistochemistri
ihc
perform
serial
section
formalinfix
sampl
dewax
rehydr
previous
describ
pedrera
et
al
briefli
endogen
peroxidas
activ
exhaust
incub
hydrogen
peroxid
methanol
min
room
temperatur
sampl
subject
differ
method
antigen
retriev
tabl
pretreat
section
rins
three
time
pb
ph
min
cover
normal
hors
serum
pierceendogen
woburn
usa
tri
buffer
salin
tb
ph
normal
goat
serum
pb
min
room
temperatur
primari
monoclon
ab
mab
polyclon
ab
pab
respect
block
stage
section
incub
primari
ab
overnight
primari
incub
slide
wash
pb
three
time
min
incub
secondari
antibodi
min
room
temperatur
biotinyl
hors
antimous
igg
secondari
ab
pierceendogen
dilut
tri
buffer
contain
normal
hors
serum
use
primari
mab
biotinyl
goat
antirabbit
igg
secondari
ab
vector
laboratori
burlingam
ca
usa
dilut
pb
contain
normal
goat
serum
use
primari
pab
three
min
wash
tb
sampl
incub
abc
complex
vectastain
w
abc
elit
kit
vector
laboratori
ca
usa
h
room
temperatur
tissu
section
final
rins
pb
incub
chromogen
solut
novar
w
substrat
kit
vector
laboratori
slide
counterstain
mayer
haematoxylin
detail
primari
mab
pab
summar
tabl
tissu
sampl
cattl
reactiv
primari
ab
cytokin
cellular
marker
use
studi
demonstr
use
posit
control
ihc
tissu
section
specif
primari
ab
replac
rabbit
mous
nonimmun
sera
dakocytom
glostrup
denmark
use
neg
control
order
evalu
number
immunolabel
cell
correl
result
obtain
use
differ
ab
two
paraffinwax
block
lung
anim
select
cell
count
carri
randomli
chosen
field
mm
tissu
section
block
result
given
number
posit
cell
per
mm
identif
differ
type
immunolabel
cell
base
morpholog
featur
locat
size
cell
differ
pulmonari
exhibit
round
elong
morpholog
indent
nucleu
abund
cytoplasm
interstiti
pulmonari
intravascular
pim
pulmonari
alveolar
pam
local
distinct
anatom
compart
lung
includ
connect
tissu
adher
endothelium
pulmonari
capillari
air
space
respect
pim
group
togeth
describ
septal
semiquantit
estim
platelet
aggreg
factorviiiposit
perform
randomli
chosen
mm
area
result
given
presenc
posit
cluster
platelet
per
area
follow
absent
mild
moder
abund
graphic
represent
statist
analysi
score
absent
sever
quantif
perform
two
experienc
observ
previou
knowledg
group
analyz
data
assess
calcul
mean
standard
error
valu
analyz
sa
system
window
version
sa
institut
cari
north
carolina
usa
chisquar
analysi
employ
estim
platelet
aggreg
factorviiiposit
p
accept
statist
signific
use
fisher
exact
test
instanc
expect
valu
duncan
multipl
rang
test
p
use
analyz
signific
differ
valu
group
variou
time
point
nonpair
student
ttest
p
use
inocul
group
time
point
main
respiratori
sign
given
risald
et
al
briefli
calv
preinfect
bvdv
show
intens
respiratori
sign
cough
mucopurul
nasal
discharg
dyspnoea
openmouth
breath
mainli
dpi
calv
group
present
moder
serou
nasal
discharg
platelet
number
within
clinic
normal
rang
calv
throughout
studi
except
anim
inocul
group
import
decreas
platelet
number
approxim
observ
hpi
presenc
bvdv
lung
coinfect
calv
detect
rtpcr
dpi
dpi
bvdv
present
sampl
cycl
threshold
valu
wherea
detect
pcr
dpi
calv
cycl
threshold
valu
contrari
detect
dpi
group
show
sampl
higher
cycl
threshold
valu
bvdv
detect
calv
throughout
studi
remark
lesion
neg
control
anim
pulmonari
parenchyma
inocul
calv
affect
interstiti
pneumonia
alveolar
septal
thicken
produc
interstiti
aggreg
mononuclear
cell
appear
alter
earlier
coinfect
calv
associ
occasion
haemorrhag
fraser
lendrum
techniqu
reveal
fibrin
microthrombi
pulmonari
venul
capillari
inocul
calv
sever
coinfect
calv
mainli
dpi
onward
figur
chang
confirm
ultrastructur
studi
togeth
presenc
fibrin
alveoli
associ
pam
inocul
group
earli
stage
figur
moreov
anim
display
intens
hyperaemia
well
interstiti
alveolar
oedema
period
find
associ
great
quantiti
platelet
whose
detect
perform
ihc
use
antifactorviii
ab
thu
neg
control
calv
ab
prompt
posit
granular
immunostain
among
sheath
capillari
cell
free
interstitium
occasion
cytoplasm
howev
inocul
group
cluster
immunostain
granular
materi
observ
blood
vessel
moreov
numer
periarteri
togeth
pam
swollen
display
intens
posit
granular
cytoplasm
reaction
inocul
group
dpi
figur
group
cluster
platelet
observ
dpi
evid
throughout
studi
associ
engulf
platelet
peak
dpi
score
valu
evalu
field
figur
subsequ
posit
reaction
vascular
lumina
diminish
consider
without
recov
thereaft
figur
signific
differ
presenc
platelet
cluster
group
throughout
studi
p
group
find
observ
dpi
similar
valu
coinfect
group
decreas
number
platelet
cluster
end
studi
figur
howev
signific
differ
incid
cluster
lung
anim
infect
ultrastructur
studi
confirm
increas
number
activ
platelet
form
multipl
aggreg
within
blood
vessel
whose
vascular
lumina
usual
appear
complet
occlud
chang
indic
activ
enlarg
deform
shape
cell
partial
total
decreas
granul
number
dilat
open
canalicular
system
common
form
platelet
aggreg
appear
mosaiclik
cluster
compris
fulli
degranul
platelet
fusion
cytoplasm
membran
occasion
membran
complet
disappear
give
rise
fine
granular
structur
low
electron
densiti
contain
vestig
platelet
organel
surround
membran
layer
group
platelet
aggreg
occur
sooner
intens
increas
dpi
figur
show
total
recoveri
end
studi
figur
group
lesion
moder
present
retriev
sign
dpi
figur
subcellular
chang
indic
slight
secretori
activ
enlarg
prolifer
dilat
rough
endoplasm
reticulum
golgi
complex
cisterna
mainli
observ
group
dpi
moreov
dpi
pim
pam
inocul
group
appear
enlarg
round
loss
filopodia
increas
number
lysosom
vari
amount
cell
debri
cytoplasm
characterist
sign
phagocyt
activ
figur
immunolabel
septal
display
similar
kinet
singl
dual
infect
inocul
although
present
differ
magnitud
see
figur
previou
page
figur
fibrin
microthrombi
pulmonari
venul
anim
preinfect
bvdv
challeng
later
coinfect
anim
present
vascular
alter
facilit
occlus
pulmonari
venul
fibrin
microthrombi
observ
fraser
lendrum
techniqu
tem
b
dpi
well
pim
enlarg
round
engulf
cell
debri
arrowhead
observ
tem
dpi
c
respons
thu
group
show
higher
number
cell
studi
peak
dpi
p
number
pam
also
significantli
higher
coinfect
calv
start
studi
show
decreas
dpi
figur
secretori
activ
observ
ultrastructur
confirm
ihc
enabl
detect
inflammatori
mediat
cell
identifi
septal
pam
detect
immunohistochem
lung
control
infect
anim
proinflammatori
cytokin
present
differ
magnitud
kinet
singl
dual
infect
septal
associ
site
inflamm
group
figur
show
slight
peak
dpi
p
wherea
group
present
longer
respons
chemic
mediat
peribronchi
area
dpi
p
figur
contrari
septal
significantli
differ
infect
group
inocul
dpi
group
calv
maintain
lower
number
septal
throughout
studi
figur
show
delay
respons
inocul
dpi
onward
contrast
group
calv
display
earli
increas
cytokin
associ
peribronchi
area
dpi
p
figur
number
pam
posit
studi
cytokin
low
inocul
group
present
slight
respons
end
studi
except
peak
singl
infect
group
dpi
figur
numer
group
immunolabel
septal
present
inosposit
cytoplasm
granul
mainli
observ
pulmonari
parenchyma
anim
infect
bvdv
figur
dpi
figur
healthi
calv
septal
present
similar
respons
inocul
although
anim
decreas
mediat
observ
later
group
contrari
number
inosposit
pam
higher
group
suffer
chang
throughout
studi
group
calv
show
signific
decreas
dpi
figur
intracellular
local
perinuclear
cytoplasm
express
scarc
lung
studi
figur
except
septal
group
dpi
p
figur
intens
express
occur
site
inflamm
injuri
mainli
oedema
correl
degre
pulmonari
inflamm
figur
object
studi
evalu
character
vascular
chang
observ
lung
healthi
calv
calv
subclin
bvd
experiment
inocul
clarifi
role
pulmonari
local
respons
secondari
pathogen
result
show
follow
inocul
group
calv
display
mononuclear
cell
infiltr
prompt
major
vascular
alter
lung
mark
intens
intravascular
coagul
small
mediums
blood
vessel
earli
stage
diseas
three
mechan
jointli
known
virchow
triad
induc
thrombosi
endotheli
wall
injuri
abnorm
blood
constitu
platelet
coagul
fibrinolyt
pathway
abnorm
blood
flow
regard
endotheli
damag
infect
human
herp
simplex
virusbelong
subfamili
shown
caus
endotheli
injuri
favor
exposur
subendotheli
tissu
releas
procoagul
mediat
howev
neither
histopatholog
ultrastructur
examin
disclos
morpholog
evid
endotheli
damag
either
inocul
group
analysi
cell
compon
involv
coagul
pathway
reveal
fibrin
deposit
intens
platelet
aggreg
pulmonari
microvasculatur
group
find
particularli
mark
group
dpi
coincid
signific
increas
rectal
temperatur
sever
clinic
respiratori
symptom
accord
cours
certain
acut
viral
infect
platelet
may
activ
vivo
lead
degranul
figur
proinflammatori
cytokin
lung
calv
without
preexist
bvdv
challeng
immunohistochem
studi
reveal
presenc
septal
pam
posit
c
associ
site
inflamm
pulmonari
parenchyma
group
dpi
howev
calv
group
present
higher
number
reactiv
b
peribronchi
area
lung
dpi
aggreg
withdraw
circul
procoagul
activ
bvdv
report
vitro
experiment
studi
increas
coinfect
calv
due
concomit
agent
lung
dpi
despit
absenc
bvdv
blood
calv
moment
inocul
complet
disappear
detect
pcr
lung
ihc
lymphoid
tissu
throughout
experi
howev
evid
stage
direct
interact
virus
platelet
would
suggest
platelet
activ
may
enhanc
indirect
mechan
includ
express
inflammatori
mediat
releas
known
play
major
role
mainten
tissu
homeostasi
studi
proinflammatori
cytokin
reveal
alter
kinet
magnitud
express
mediat
prompt
chang
coagul
increas
number
endotheli
adhes
molecul
increas
vascular
permeabl
thu
group
calv
display
increas
synthesi
septal
coincid
onset
platelet
aggreg
lung
dpi
togeth
subsequ
action
would
favor
mainten
procoagul
set
contrast
group
calv
whilst
exhibit
higher
number
main
produc
cytokinesdisplay
inhibit
express
dpi
along
minim
respons
impair
cytokin
product
also
observ
system
level
indic
synerg
action
chemic
mediat
rule
potenti
mechan
induc
platelet
aggreg
coinfect
group
calv
inocul
ncp
bvdv
dpi
group
display
greater
express
ino
septal
healthi
calv
howev
follow
inocul
group
calv
exhibit
earli
declin
ino
dpi
inflammatori
mediat
limit
extent
durat
pathogeninduc
platelet
activ
find
togeth
moder
respons
may
favor
appear
platelet
aggreg
earli
stage
diseas
intens
aggreg
coincid
greatest
decreas
ino
level
dpi
intens
platelet
aggreg
observ
lung
microvasculatur
group
dpi
togeth
increas
number
size
pim
result
phagocyt
secretori
activ
would
indirectli
prompt
slowdown
blood
flow
subsequ
respons
enzym
aim
revers
process
howev
view
damag
observ
later
stage
action
presum
unabl
counter
procoagul
event
associ
drop
ino
express
addit
enhanc
delay
action
coinfect
anim
slow
blood
flow
togeth
cytokin
releas
may
lead
increas
vascular
permeabl
extravas
leukocyt
pulmonari
parenchyma
therefor
result
studi
indic
concomit
bvdv
lung
enhanc
synerg
action
pathogen
mechan
disrupt
mainten
pulmonari
homeostasi
facilit
establish
inflammatori
procoagul
environ
characterist
brdc
appear
modul
inflammatori
mediat
releas
pulmonari
respect
research
requir
possibl
involv
concomit
use
live
bvdv
vaccin
trigger
impair
pulmonari
immun
respons
contrari
anim
preinocul
bvdvdespit
suffer
transient
infect
exhibit
alter
respons
proinflammatori
cytokin
play
key
role
activ
immun
respons
